Quantcast

Latest Mount Sinai Hospital, New York Stories

2013-09-17 23:01:33

ABSORB III nationwide clinical trial evaluating the efficiency and safety of absorb drug-eluting Bioresorbable Vascular Scaffolds (Absorb BVS) for coronary artery disease patients. New York, NY (PRWEB) September 17, 2013 The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery blockages. The randomized trial aims to compare...

2013-09-13 23:03:02

Study Reveals Network of Genes that Safeguard Cooperation in Stem Cells and the Developing Embryo New York, NY (PRWEB) September 13, 2013 We often think of human cells as tiny computers that perform assigned tasks, where disease is a result of a malfunction. But in the current issue of Science, researchers at The Mount Sinai Medical Center offer a radical view of health — seeing it more as a cooperative state among cells, while they see disease as result of cells at war that fight...

2013-09-11 23:17:45

Mount Sinai is promoting the scientific discoveries of its faculty by facilitating the establishment and supporting incubator companies to accelerate the discovery of treatments for devastating diseases, including those that often affect relatively small populations. New York, NY (PRWEB) September 11, 2013 Mount Sinai Innovation Partners (MSIP), part of the Icahn School of Medicine at Mount Sinai, has granted an exclusive license to Plexcera Therapeutics, LLC to commercially develop...

2013-09-11 23:03:02

The Mount Sinai Medical Center is ranked #4 out of the 50 Most Social Media Friendly Hospitals in the United States. It was also the only hospital in the New York City metropolitan area to rank in the top 15. New York, NY (PRWEB) September 11, 2013 The Mount Sinai Medical Center is ranked #4 out of the 50 Most Social Media Friendly Hospitals in the United States. It was also the only hospital in the New York City metropolitan area to rank in the top 15. The rankings, from MHADegree.org,...

2013-09-10 23:20:15

NIH Consortium Seeks to Predict, Develop Prevention Strategies, and Understand Common Liver Injury Caused by Medications New York, NY (PRWEB) September 10, 2013 In an effort to better understand and develop prevention strategies for drug-induced liver injury (DILI), physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network (DILIN), a National Institutes of Health-funded consortium of only six academic medical centers in the...

2013-09-05 23:20:11

Colorectal Cancer Mortality is 49 Percent Higher Among African Americans New York, NY (PRWEB) September 05, 2013 Researchers at the Icahn School of Medicine at Mount Sinai have received a multi-year National Institutes of Health (NIH) grant to determine factors which may influence why African Americans are less likely than others to receive colorectal cancer (CRC) screenings, despite having the highest CRC incidence and mortality of any ethnic/racial group in America. “The short-term...

2013-09-04 23:01:47

Dr. Longtine’s Election Results in a Three-Year Term on the Board of Directors and Executive Committee New York, NY (PRWEB) September 04, 2013 Janina A. Longtine, MD, has been elected President of the Association for Molecular Pathology (AMP), an international medical professional association dedicated to advancing the clinical practice, science and excellence of molecular and genomic laboratory medicine through education, innovation and advocacy to enable highest quality health care....

2013-09-03 23:04:06

Researchers from the Icahn School of Medicine at Mount Sinai recently published two manuscripts in the New England Journal of Medicine regarding a new antibody used to treat both ulcerative colitis and Crohn’s disease. New York, NY (PRWEB) September 03, 2013 Researchers from the Icahn School of Medicine at Mount Sinai recently published two manuscripts in the New England Journal of Medicine regarding a new antibody used to treat both ulcerative colitis and Crohn’s disease. The journal...

2013-09-02 23:00:52

Worldwide study of more than 11,000 female patients provides evidence that stents can be safe and efficient in women who are traditionally underrepresented in clinical trials. New York, NY (PRWEB) September 02, 2013 Cardiac stents to open blocked heart arteries and reduce chest pain have been used for decades. However, cardiologists have never been certain that women benefitted from their use because clinical trials testing stents only included, at most, 25 percent women, making the...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related